Star Equity Holdings, Inc. Declares a Partial Cash Dividend of $0.225 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

Star Equity Holdings, Inc. Declares a Partial Cash Dividend of $0.225 Per Share of 10% Series A Cumulative Perpetual Preferred Stock The dividend will cover the period through August 21, 2025 GlobeNewswire August 08, 2025 OLD GREENWICH, Conn., Aug. 08, 2025 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star” or the “Company”), […]

Verde Announces Q2 2025 Earnings Results

(TSX:NPK),(OTC US:VNPKF),(Other OTC:VNPKF), SINGAPORE, Aug. 08, 2025 (GLOBE NEWSWIRE) — Verde AgriTech Ltd (TSX: “NPK”) (“Verde” or the “Company“) announces its financial results for the period ended June 30, 2025 (“Q2 2025“). All figures are in Canadian dollars, unless stated otherwise. Average exchange rate in Q2 2025: C$1.00 = R$4.08. Q2 2025 HIGHLIGHTS Operational and

Verde Announces Q2 2025 Earnings Results

Verde Announces Q2 2025 Earnings Results GlobeNewswire August 08, 2025 SINGAPORE, Aug. 08, 2025 (GLOBE NEWSWIRE) — Verde AgriTech Ltd (TSX: “NPK”) (“Verde” or the “Company“) announces its financial results for the period ended June 30, 2025 (“Q2 2025“). All figures are in Canadian dollars, unless stated otherwise. Average exchange rate in Q2 2025: C$1.00

KOIL Energy Solutions Schedules Q2 2025 Earnings Release and Conference Call

(Other OTC:KLNG),(OTC US:KLNG), HOUSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) — Koil Energy Solutions, Inc. (OTCQB: KLNG), announced today that it will file its Quarterly Report on Form 10-Q for the second quarter of 2025 on Thursday, August 14, 2025. KOIL will host an investor conference call to review its second quarter of 2025 results on

KOIL Energy Solutions Schedules Q2 2025 Earnings Release and Conference Call

KOIL Energy Solutions Schedules Q2 2025 Earnings Release and Conference Call GlobeNewswire August 08, 2025 HOUSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) — Koil Energy Solutions, Inc. (OTCQB: KLNG), announced today that it will file its Quarterly Report on Form 10-Q for the second quarter of 2025 on Thursday, August 14, 2025. KOIL will host an

Dorel Reports Second Quarter 2025 Results

(TSX:DII-B.TO),(TSX:DII-A.TO), Dorel Juvenile delivers solid earnings performance led by growth in international markets Dorel Home implementing restructuring strategy amidst a challenging market MONTRÉAL, Aug. 08, 2025 (GLOBE NEWSWIRE) — Dorel Industries Inc. (TSX: DII.B, DII.A) today announced its financial results for the second quarter and six months ended June 30, 2025. Second quarter revenue was

AVALON HOLDINGS CORPORATION ANNOUNCES SECOND QUARTER RESULTS

Avalon Holdings Corporation (NYSE Amex: AWX) today announced financial results for the second quarter of 2025. https://mma.prnewswire.com/media/2142492/Avalon_Holdings_Corporation_Logo.jpg Net operating revenues in the second quarter of 2025 were $20.3 million compared with $23.1 million in the second quarter of 2024. The Company recorded net income attributable to Avalon Holdings Corporation common shareholders of $0.3 million in

Dorel Reports Second Quarter 2025 Results

Dorel Reports Second Quarter 2025 Results GlobeNewswire August 08, 2025 Dorel Juvenile delivers solid earnings performance led by growth in international markets Dorel Home implementing restructuring strategy amidst a challenging market MONTRÉAL, Aug. 08, 2025 (GLOBE NEWSWIRE) — Dorel Industries Inc. (TSX: DII.B, DII.A) today announced its financial results for the second quarter and six

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

(NASDAQ:OCGN), MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it has entered into a securities purchase agreement with Janus Henderson Investors, a global asset management firm, to purchase 20,000,000 shares of common stock and

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants GlobeNewswire August 08, 2025 MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it has entered into a securities purchase agreement with

Scroll to Top